
William K. Cheung
Examiner (ID: 3964)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1796, 1713, 1762 |
| Total Applications | 2398 |
| Issued Applications | 1935 |
| Pending Applications | 41 |
| Abandoned Applications | 433 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18695069
[patent_doc_number] => 20230325487
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/208247
[patent_app_country] => US
[patent_app_date] => 2023-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 297
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18208247
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/208247 | PRODUCTION OF THERAPEUTICS POTENTIAL MESENCHYMAL STEM CELLS | Jun 8, 2023 | Pending |
Array
(
[id] => 18844854
[patent_doc_number] => 20230407258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/321121
[patent_app_country] => US
[patent_app_date] => 2023-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18321121
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/321121 | TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS THEREOF | May 21, 2023 | Pending |
Array
(
[id] => 18771118
[patent_doc_number] => 20230365928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => CORTICAL INTERNEURONS AND OTHER NEURONAL CELLS PRODUCED BY THE DIRECTED DIFFERENTIATION OF PLURIPOTENT AND MULTIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 18/296779
[patent_app_country] => US
[patent_app_date] => 2023-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42568
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18296779
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/296779 | CORTICAL INTERNEURONS AND OTHER NEURONAL CELLS PRODUCED BY THE DIRECTED DIFFERENTIATION OF PLURIPOTENT AND MULTIPOTENT CELLS | Apr 5, 2023 | Issued |
Array
(
[id] => 19249041
[patent_doc_number] => 20240200028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => CULTURE MEDIUM, COATING MATRIX AND METHOD FOR MATURING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 18/119692
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119692
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/119692 | Culture medium, coating matrix and method for maturing midbrain dopaminergic progenitor cells | Mar 8, 2023 | Issued |
Array
(
[id] => 19249040
[patent_doc_number] => 20240200027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => CULTURE MEDIUM, COATING MATRIX AND METHOD FOR EXPANDING MIDBRAIN DOPAMINERGIC PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 18/119682
[patent_app_country] => US
[patent_app_date] => 2023-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19883
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18119682
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/119682 | Culture medium, coating matrix and method for expanding midbrain dopaminergic progenitor cells | Mar 8, 2023 | Issued |
Array
(
[id] => 18626667
[patent_doc_number] => 20230285467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => METHODS FOR OBTAINING MUSCLE DERIVED CELLS
[patent_app_type] => utility
[patent_app_number] => 18/180377
[patent_app_country] => US
[patent_app_date] => 2023-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18180377
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/180377 | METHODS FOR OBTAINING MUSCLE DERIVED CELLS | Mar 7, 2023 | Pending |
Array
(
[id] => 18467144
[patent_doc_number] => 20230201425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => BIOMATERIALS FOR ENHANCED IMPLANT-HOST INTEGRATION
[patent_app_type] => utility
[patent_app_number] => 18/107308
[patent_app_country] => US
[patent_app_date] => 2023-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18107308
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/107308 | BIOMATERIALS FOR ENHANCED IMPLANT-HOST INTEGRATION | Feb 7, 2023 | Pending |
Array
(
[id] => 18420455
[patent_doc_number] => 20230174917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Cell Growth With Mechanical Stimuli
[patent_app_type] => utility
[patent_app_number] => 18/161291
[patent_app_country] => US
[patent_app_date] => 2023-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18161291
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/161291 | Cell Growth With Mechanical Stimuli | Jan 29, 2023 | Pending |
Array
(
[id] => 18294058
[patent_doc_number] => 20230103744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Compositions Derived from Placenta and Methods of Producing the Same
[patent_app_type] => utility
[patent_app_number] => 18/070908
[patent_app_country] => US
[patent_app_date] => 2022-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070908
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070908 | Compositions Derived from Placenta and Methods of Producing the Same | Nov 28, 2022 | Pending |
Array
(
[id] => 18258355
[patent_doc_number] => 20230085395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => STEM CELL DERIVED ISLET DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 18/055327
[patent_app_country] => US
[patent_app_date] => 2022-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18055327
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/055327 | STEM CELL DERIVED ISLET DIFFERENTIATION | Nov 13, 2022 | Abandoned |
Array
(
[id] => 18244218
[patent_doc_number] => 20230076529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => SC-BETA CELLS AND COMPOSITIONS AND METHODS FOR GENERATING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/978936
[patent_app_country] => US
[patent_app_date] => 2022-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17978936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/978936 | SC-beta cells and compositions and methods for generating the same | Oct 31, 2022 | Issued |
Array
(
[id] => 18169551
[patent_doc_number] => 20230036162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CELL CULTURE SUBSTRATES, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/966281
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966281
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966281 | CELL CULTURE SUBSTRATES, METHODS AND USES THEREOF | Oct 13, 2022 | Pending |
Array
(
[id] => 18270099
[patent_doc_number] => 20230091341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => CELL CULTURE SUBSTRATES, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/958234
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958234 | Cell culture substrates, methods and uses thereof | Sep 29, 2022 | Issued |
Array
(
[id] => 18184249
[patent_doc_number] => 20230044979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => ANIMAL CELL CULTURING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/943792
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17943792
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/943792 | ANIMAL CELL CULTURING METHOD | Sep 12, 2022 | Abandoned |
Array
(
[id] => 18058291
[patent_doc_number] => 20220389377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => TREATMENT OF MEDICAL CONDITIONS BY STEM CELL TRANSPLANTS AND STEM CELL ACTIVATION
[patent_app_type] => utility
[patent_app_number] => 17/819886
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819886
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819886 | TREATMENT OF MEDICAL CONDITIONS BY STEM CELL TRANSPLANTS AND STEM CELL ACTIVATION | Aug 14, 2022 | Abandoned |
Array
(
[id] => 18199385
[patent_doc_number] => 20230052904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => CHEMICALLY DEFINED SERUM REPLACEMENTS FOR CELL CULTURE
[patent_app_type] => utility
[patent_app_number] => 17/879390
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879390
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879390 | Chemically defined serum replacements for cell culture | Aug 1, 2022 | Issued |
Array
(
[id] => 17958718
[patent_doc_number] => 20220339298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => SPERM NUCLEI AND METHODS OF THEIR MANUFACTURE AND USE
[patent_app_type] => utility
[patent_app_number] => 17/863202
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863202
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863202 | SPERM NUCLEI AND METHODS OF THEIR MANUFACTURE AND USE | Jul 11, 2022 | Pending |
Array
(
[id] => 17982600
[patent_doc_number] => 20220348636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN
[patent_app_type] => utility
[patent_app_number] => 17/859466
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17859466
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/859466 | METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN | Jul 6, 2022 | Pending |
Array
(
[id] => 17944467
[patent_doc_number] => 20220331484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Compositions Derived from Placenta and Methods of Producing the Same
[patent_app_type] => utility
[patent_app_number] => 17/858146
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858146
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858146 | Compositions Derived from Placenta and Methods of Producing the Same | Jul 5, 2022 | Pending |
Array
(
[id] => 18337319
[patent_doc_number] => 20230129268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PLATELET RICH PLASMA FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/806207
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806207 | PLATELET RICH PLASMA FORMULATIONS | Jun 8, 2022 | Pending |